
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Hamas hands over another body in the Gaza Strip - 2
Dozens of hidden star streams found in the outskirts of our Milky Way galaxy - 3
6 Methods for further developing Rest Quality - 4
The most effective method to Pick The Right Speakers - 5
France will build a new aircraft carrier as it increases defense spending
Island Travel Guide: Must-Visit Objections for 2024
the 6 Shrewd Beds for seniors: A Complete Survey
Discovery off Israel’s coast reveals earliest known 2,600-year-old shipment of raw iron
Former school bus aide pleads guilty to assaulting 3 autistic students in Colorado
Huge solar flare no threat to Artemis 2 astronaut launch to the moon, NASA says
6 Robot Vacuum Cleaners for Easy Home Cleaning
I served on the expert committee that advised the government on new dietary guidelines – most of our recommendations were ignored
Purchases of iPhone 17 Pro soar across Gaza amid 'limited' humanitarian aid
Hubble Space Telescope spies dusty debris from two cosmic collisions













